Sandra Castaño‐Díez

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Álex Bataller, Ana Garrido, Francesca Guijarro et al. · Blood Advances · 2021 · 56 citations · Full text

Medicine, Hematology, Oncology +13

Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines

Pedro Puerta‐Alcalde, Mariana Chumbita, Paola Charry et al. · Transplantation and Cellular Therapy · 2021 · 25 citations · Full text

Medicine, Hematology, Infectious Diseases +14

The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever

Luis Gerardo Rodríguez‐Lobato, Alexandra Martínez‐Roca, Sandra Castaño‐Díez et al. · PLoS ONE · 2020 · 19 citations · Full text

Medicine, Hematology, Oncology +17

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

Sandra Castaño‐Díez, Mònica López‐Guerra, Cristina Bosch-Castañeda et al. · Cancers · 2022 · 15 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome

Francesca Guijarro, Mònica López‐Guerra, Jordi Morata et al. · Blood Advances · 2023 · 15 citations · Full text

Life Sciences, Genetics, Hematology +17